Veriheal

APRIL 23, 2024

Report: Gen Z Would Rather Smoke Cannabis Than Consume Alcohol To collect this data, Veriheal surveyed thousands of patients between the ages of 15 and 27 who signed up for our services between March 2023 and April 2024. Chronic pain and “other” are the second highest reasons.

Chronic Pain 109

Chronic Pain Data Edibles Sleep 109

MMJ Recs

DECEMBER 15, 2021

These states recognize MMJ cards from other states and allow patients with out-of-state cards to purchase medical marijuana legally in local dispensaries. This means that MMJ patients from other states will be able to purchase recreational marijuana in New York from late 2022. Patients can grow up to six plants at home.

Chronic Pain 98

Chronic Pain Dispensary Recreational Patients 98

The Cannigma

JULY 1, 2022

As of June 2022, there were just five medical marijuana dispensaries to serve the entire state. The medical program for Iowa patients is limited. Lack of access to dispensaries, limited product availability, and no health insurance coverage all drive up the cost for medical patients. Iowa Medical Marijuana Program.

Chronic Pain 52

Chronic Pain Legalization Programs Recreational 52

Peninsula Alternative Health

AUGUST 30, 2022

As a medical cannabis dispensary, we help 1000s of patients find medicine that helps them in their daily lives. While people can discover many positive benefits of medical cannabis, the #1 reason they may opt for cannabis is in the pursuit of pain relief. These natural compounds mainly consist of cannabinoids and terpenes.

Chronic Pain 52

Chronic Pain Medicine Terpenes Sleep 52

Cannabis Law Report

JANUARY 24, 2022

DUBLIN–(BUSINESS WIRE)–The “North America Legal Cannabis Market Size, Share & Trends Analysis Report by Sources (Marijuana, Hemp), by Derivatives (CBD, THC), by End Use (Medical, Recreational), and Segment Forecasts, 2022-2028” report has been added to ResearchAndMarkets.com’s offering. from 2022 to 2028.

Legalization 52

Legalization Supply Chain Chronic Pain Recreational 52

Cannabis Law Report

JULY 24, 2022

The legal framework regarding the use of psychedelics in patients is very pragmatic in Switzerland and unique internationally. Nevertheless, the regulatory hurdles for researchers and patients are still extremely high. A total of 170 patients were treated under these licenses. percent annually to $9.8 billion by 2029. [1]

Research and Development 52

Research and Development Legalization Treatment Patients 52

Cannabis Law Report

MAY 10, 2022

11 May 2022. Pain, anxiety and sleep issues are often interconnected – chronic pain can also cause mental health and sleep issues.”. Apart from the link between anxiety and flower products, we found other interesting associations, for example, prescriptions of topical CBD for convulsions,” Dr Cairns said.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Cannabis Law Report

OCTOBER 20, 2019

She is currently a law school professor teaching Marijuana and the Law at California Western School of Law and researcher under a contract with NHTSA and NORC on the topic of the prosecution of drugged driving cases. It is also the first FDA approved drug for the treatment of patients with Dravet syndrome. as a Schedule II substance.

Marijuana 45

Marijuana Pharmaceutical Chronic Pain Research and Development 45

Kind Meds (Cannabis Education Blog)

AUGUST 8, 2023

Whether you need to address chronic pain, get better sleep, deal with mental or physical stress, or simply enjoy partaking in the joys of cannabis, we hope you’ll consider our Mesa dispensary. You may prefer to use topicals containing cannabis, but you’re out of luck if the local dispensary only carries edibles and flower.

Dispensary 52

Dispensary Concentrates Vaping Safety 52

The Cannigma

JANUARY 13, 2023

Treating migraine pain is one of the instances where inhaled cannabis consumption, such as smoking or vaping , is important for the right effects and speed of delivery. Edibles won’t produce the same experience, but topicals may be able to help, too. Chronic migraines can make it incredibly challenging to hold down a job.

Terpenes 132

Terpenes Strains THC Treatment 132

The Cannigma

DECEMBER 12, 2022

Using integration or psychotherapy along with these medicines allows patients to incorporate the positive effects permanently. Current clinical trials are underway using a synthetic nasal spray of 5-MeO-DMT in patients with major depressive disorder. The after-glow is essentially the opposite of a hangover.

History 119

History Microdosing Research and Development Clinical Trials 119

Cannabis Law Report

DECEMBER 20, 2021

First Patient Expected to be Enrolled by Q2 of 2022. Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, signed a clinical trial agreement with Altasciences Company, Inc., BERWYN, Pa.–(BUSINESS

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Data 52

Veriheal

AUGUST 31, 2021

She provides clear strategies for teaching healthcare professionals how to improve their proficiency and cultural competency for caring for medical marijuana patients. Such a flow of information would empower medical marijuana patients to review the chemical contents, benefits and side effects, and allergy information for products.

Research and Development 116

Research and Development Supply Chain Programs Education 116

The Joint Blog

MAY 13, 2020

So we reached out to Eloise Theisen , RN, MSN, AGPCNP-BC, Pacific College of Health and Science faculty ( Medical Cannabis program ), and President of the American Cannabis Nurse Association to get her take on topic. Cannabinoids have been shown to improve mood, focus and energy as well as decrease pain and inflammation.

Blood Pressure 52

Blood Pressure Tincture Cannabinoids Topical 52

Cannabis Law Report

DECEMBER 28, 2021

We recently announced that we anticipate commencing our initial human trial for Epoladerm™ in the second quarter of 2022. Virpax initially focused strictly on pain product candidates. Virpax anticipates enrollment of the first patient by early second quarter of 2022. to conduct this study in Canada.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

NOVEMBER 15, 2021

Our lead product candidate is Envelta™, which utilizes MET to deliver enkephalin nanoparticles for acute and chronic pain including pain associated with cancer. Sinclair is expected to begin the preclinical animal studies at the beginning of 2022 as part of the enabling trials for an IND application with the FDA.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

SpeedWeed

MAY 8, 2021

Alabama’s Senate Bill 46 , which was amended and cleared by two House committees last month, would allow registered patients diagnosed with a qualifying condition to access cannabis, making it the 37th medical cannabis state if passed, according to Marijuana Policy Project. May 6, when the bill is expected to return to the chamber’s floor.

Business 52

Business Seed-To-Sale Chronic Pain Patients 52

SpeedWeed

MAY 6, 2021

Alabama’s Senate Bill 46 , which was amended and cleared by two House committees last month, would allow registered patients diagnosed with a qualifying condition to access cannabis, making it the 37th medical cannabis state if passed, according to Marijuana Policy Project. May 6, when the bill is expected to return to the chamber’s floor.

Programs 52

Programs Retail Seed-To-Sale Chronic Pain 52

SpeedWeed

MAY 6, 2021

Alabama’s Senate Bill 46 , which was amended and cleared by two House committees last month, would allow registered patients diagnosed with a qualifying condition to access cannabis, making it the 37th medical cannabis state if passed, according to Marijuana Policy Project. May 6, when the bill is expected to return to the chamber’s floor.

Seed-To-Sale 52

Seed-To-Sale Chronic Pain Patients Legislation 52

Cannabis Law Report

NOVEMBER 29, 2021

As we approach the 2022 legislative session and the elections next November, it is important for lawmakers of all political persuasions to recognize that advocating for marijuana policy reforms is a political opportunity, not a political liability,” NORML’s Paul Armentano said. Patients must obtain cannabis from a licensed dispensary.

Legislation 98

Legislation Patients Retail Access 98

SpeedWeed

MAY 7, 2021

After a nearly 10-hour filibuster Tuesday, House lawmakers reconvened Thursday and considered several floor amendments before passing the Senate-originated bill, 68-34, which would allow registered patients diagnosed with qualifying conditions to access cannabis. Sponsored by Republican Sen. Tim Melson, S.B. Republican Rep. If enacted, S.B.

Legislation 52

Legislation Seed-To-Sale Patients Chronic Pain 52

SpeedWeed

MAY 19, 2021

When the Alabama Legislature passed its medical cannabis bill earlier this month, MPP Director of State Policies Karen O’Keefe said the legislation will allow seriously ill patients to finally get the relief they deserve and urged Ivey to sign it into law. Ivey did just that Monday afternoon. “I I would like to thank Sen. Tim Melson and Rep.

Legislation 52

Legislation Seed-To-Sale Patients Conditions 52

SpeedWeed

MAY 18, 2021

When the Alabama Legislature passed its medical cannabis bill earlier this month, MPP Director of State Policies Karen O’Keefe said the legislation will allow seriously ill patients to finally get the relief they deserve and urged Ivey to sign it into law. Ivey did just that Monday afternoon. “I I would like to thank Sen. Tim Melson and Rep.

THC 52

THC Legislation Seed-To-Sale Patients 52

SpeedWeed

MAY 17, 2021

When the Alabama Legislature passed its medical cannabis bill earlier this month, MPP Director of State Policies Karen O’Keefe said the legislation will allow seriously ill patients to finally get the relief they deserve and urged Ivey to sign it into law. Ivey did just that Monday afternoon. “I I would like to thank Sen. Tim Melson and Rep.

Legislation 52

Legislation Seed-To-Sale Patients Conditions 52

SpeedWeed

MAY 17, 2021

When the Alabama Legislature passed its medical cannabis bill earlier this month, MPP Director of State Policies Karen O’Keefe said the legislation will allow seriously ill patients to finally get the relief they deserve and urged Ivey to sign it into law. Ivey did just that Monday afternoon. “I I would like to thank Sen. Tim Melson and Rep.

Legislation 52

Legislation Seed-To-Sale Patients Conditions 52

SpeedWeed

MAY 10, 2021

After a nearly 10-hour filibuster Tuesday, House lawmakers reconvened Thursday and considered several floor amendments before passing the Senate-originated bill, 68-34, which would allow registered patients diagnosed with qualifying conditions to access cannabis. Sponsored by Republican Sen. Tim Melson, S.B. Republican Rep. If enacted, S.B.

Recreational 52

Recreational Marijuana Legislation Seed-To-Sale 52

SpeedWeed

MAY 8, 2021

After a nearly 10-hour filibuster Tuesday, House lawmakers reconvened Thursday and considered several floor amendments before passing the Senate-originated bill, 68-34, which would allow registered patients diagnosed with qualifying conditions to access cannabis. Sponsored by Republican Sen. Tim Melson, S.B. Republican Rep. If enacted, S.B.

Legislation 52

Legislation Seed-To-Sale Patients Chronic Pain 52

SpeedWeed

MAY 7, 2021

After a nearly 10-hour filibuster Tuesday, House lawmakers reconvened Thursday and considered several floor amendments before passing the Senate-originated bill, 68-34, which would allow registered patients diagnosed with qualifying conditions to access cannabis. Sponsored by Republican Sen. Tim Melson, S.B. Republican Rep. If enacted, S.B.

Legislation 52

Legislation Seed-To-Sale Patients Chronic Pain 52

SpeedWeed

MAY 18, 2021

When the Alabama Legislature passed its medical cannabis bill earlier this month, MPP Director of State Policies Karen O’Keefe said the legislation will allow seriously ill patients to finally get the relief they deserve and urged Ivey to sign it into law. Ivey did just that Monday afternoon. “I I would like to thank Sen. Tim Melson and Rep.

Legislation 52

Legislation Seed-To-Sale Patients Conditions 52

SpeedWeed

MAY 10, 2021

After a nearly 10-hour filibuster Tuesday, House lawmakers reconvened Thursday and considered several floor amendments before passing the Senate-originated bill, 68-34, which would allow registered patients diagnosed with qualifying conditions to access cannabis. Sponsored by Republican Sen. Tim Melson, S.B. Republican Rep. If enacted, S.B.

Legislation 52

Legislation Seed-To-Sale Patients Chronic Pain 52